3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Lung Neoplasms
16
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
6
Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Fatigue
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Skin Carcinoma
2
Papillomavirus Infections
2
Malignant Solid Neoplasm
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Gastrointestinal Neoplasms
2
Interventions
Cisplatin
6
pembrolizumab
5
Nivolumab
5
palbociclib
4
durvalumab
4
Pemetrexed
4
atezolizumab
3
abemaciclib
3
Fulvestrant
3
Carboplatin
3
Anastrozole
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
ribociclib
2
relatlimab
2
entrectinib
2
cobimetinib
2
capmatinib
2
alectinib
2
Vemurafenib
2
Radiosurgery
2
Paclitaxel
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Gemcitabine
2
Bevacizumab
2
AZD9833
2
trametinib
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Educational Status
×
1 year
×
Clear all
No trials found.